Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 June 2018 Photo Thabo Kessah
Young researcher to jet out to UK
Mamosa Ngcala who leaving for the United Kingdom on 31 July 2018.

When Mamosa Ngcala jets out to the United Kingdom (UK) on 31 July 2018, she will not only be doing research and improving herself academically at the Durham University, but she will also put yet another feather in the growing research profile cap of the Qwaqwa Campus.

“I am looking forward to my study visit under the mentorship of Dr Steve Chivasa, my supervisor’s co-researcher in the Department of Biosciences at the renowned Durham University. This will enable me to grow academically as much as it will get me closer to concluding my research on climate change and food security,” said Mamosa, a master’s student in Science (Botany). Her supervisor is Dr Rudo Ngara.

“Going there will fast-track my research that looks at how food security can be enhanced in as far as growing sorghum is concerned. This study in Plant Biotechnology aims to identify heat responsive genes in sorghum, which is the fifth most important cereal crop in the world. The information obtained in this study will serve as fundamental knowledge regarding molecular responses of plants to heat stress and will be used in breeding programmes to develop crops that can tolerate high temperature stress conditions caused by climate change, thus resulting in high crop yield in agriculture as well as food security,” she said. She will be in the UK until 12 September 2018.

Mamosa has recently won the 3-Minute thesis competition for graduates that was part of the ‘Sorghum in the 21st Century’ international conference held in Cape Town.

Talking about this achievement, she said: “Going head-to-head with PhD students from all over the world gave me extra motivation and drive to do well, and I did. This goes to show that we can achieve whatever we put our minds to. Having to summarise my entire study in three minutes for a non-specialist audience, using one PowerPoint slide, was a challenge that had to be overcome,” said Mamosa. The conference was organised by the Collaborative Research on Sorghum and Millet and the University of Pretoria.

Mamosa graduated with distinction in Botany for her honours degree. She is a member of the Golden Key International Honour Society and Chairperson of the Postgraduate Student Council and is looking forward to advancing her studies to PhD level.

News Archive

Stem cell research and human cloning: legal and ethical focal points
2004-07-29

   

(Summary of the inaugural lecture of Prof Hennie Oosthuizen, from the Department of Criminal and Medical Law at the Faculty of Law of the University of the Free State.)

 

In the light of stem cell research, research on embryo’s and human cloning it will be fatal for legal advisors and researchers in South Africa to ignore the benefits that new bio-medical development, through research, contain for this country.

Legal advisors across the world have various views on stem cell research and human cloning. In the USA there is no legislation that regulates stem cell research but a number of States adopted legislation that approves stem cell research. The British Parlement gave permission for research on embryonic stem cells, but determined that it must be monitored closely and the European Union is of the opinion that it will open a door for race purification and commercial exploitation of human beings.

In South Africa the Bill on National Health makes provision for therapeutical and non therapeutical research. It also makes provision for therapeutical embryonical stem cell research on fetuses, which is not older than 14 days, as well as for therapeutical cloning under certain circumstances subject to the approval of the Minister. The Bill prohibits reproductive cloning.

Research on human embrio’s is a very controversial issue, here and in the rest of the world.

Researchers believe that the use of stem cell therapy could help to side-step the rejection of newly transplanted organs and tissue and if a bank for stem cell could be built, the shortage of organs for transplants would become something of the past. Stem cells could also be used for healing of Alzheimer’s, Parkinson’s and spinal injuries.

Sources from which stem cells are obtained could also lead to further ethical issues. Stem cells are harvested from mature human cells and embryonic stem cells. Another source to be utilised is to take egg cells from the ovaries of aborted fetuses. This will be morally unacceptable for those against abortions. Linking a financial incentive to that could become more of a controversial issue because the woman’s decision to abort could be influenced. The ideal would be to rather use human fetus tissue from spontaneous abortions or extra-uterine pregnancies than induced abortions.

The potential to obtain stem cells from the blood of the umbilical cord, bone-marrow and fetus tissue and for these cells to arrange themselves is known for quite some time. Blood from the umbilical cord contains many stem cells, which is the origin of the body’s immune and blood system. It is beneficial to bank the blood of a newborn baby’s umbilical cord. Through stem cell transplants the baby or another family member’s life could be saved from future illnesses such as anemia, leukemia and metabolic storing disabilities as well as certain generic immuno disabilities.

The possibility to withdraw stem cells from human embrio’s and to grow them is more useable because it has more treatment possibilities.

With the birth of Dolly the sheep, communities strongly expressed their concern about the possibility that a new cloning technique such as the replacement of the core of a cell will be used in human reproduction. Embryonic splitting and core replacement are two well known techniques that are associated with the cloning process.

I differentiate between reproductive cloning – to create a cloned human embryo with the aim to bring about a pregnancy of a child that is identical to another individual – and therapeutically cloning – to create a cloned human embryo for research purposes and for healing human illnesses.

Worldwide people are debating whether to proceed with therapeutical cloning. There are people for and against it. The biggest ethical objection against therapeutical cloning is the termination of the development of a potential human being.

Children born from cloning will differ from each other. Factors such as the uterus environment and the environment in which the child is growing up will play a role. Cloning create unique children that will grow up to be unique individuals, just like me and you that will develop into a person, just like you and me. If we understand this scientific fact, most arguments against human cloning will disappear.

Infertility can be treated through in vitro conception. This process does not work for everyone. For some cloning is a revolutionary treatment method because it is the only method that does not require patients to produce sperm and egg cells. The same arguments that were used against in vitro conception in the past are now being used against cloning. It is years later and in vitro cloning is generally applied and accepted by society. I am of the opinion that the same will happen with regard to human cloning.

There is an argument that cloning must be prohibited because it is unsafe. Distorted ideas in this regard were proven wrong. Are these distorted ideas justified to question the safety of cloning and the cloning process you may ask. The answer, according to me, is a definite no. Human cloning does have many advantages. That includes assistance with infertility, prevention of Down Syndrome and recovery from leukemia.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept